Journal
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
Volume 7, Issue 7, Pages 615-628Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/17474124.2013.832501
Keywords
Clostridium difficile; fecal microbiota transplant; intestinal microbiome; probiotics
Categories
Ask authors/readers for more resources
Clostridium difficile infection is increasingly common with a high risk of recurrence despite antibiotic treatment. In cases of recurrent C. difficile infection, fecal microbiota transplant (FMT) is a highly effective treatment option promoting the restoration of normal gut microbiota. Furthermore, preliminary uncontrolled evidence demonstrates possible benefit of FMT in the management of some cases of inflammatory bowel disease and chronic constipation. In addition to presenting an overview of FMT, we discuss the role of probiotics, a more common approach to modifying the intestinal microbiome. Probiotics have been utilized broadly for many disease processes, including gastrointestinal, cardiovascular and allergic disease settings, although with limited and inconsistent results. Multiple potential areas for research are also identified.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available